Rhenman & Partners Asset Management AB
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1599882
Stockholm, V7
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,242,160
-$4,175,631 QoQ
Shares Held
30,685
-29.4% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
1.44%
of 13F equity value
Holder Rank
#294
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rhenman & Partners Asset Management AB holds $335,352,902 across 39 Biotechnology names. VRTX ranks #8 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
87,440 | $21,070,416 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
27,390 | $17,078,760 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
290,500 | $16,622,410 | |
| 4 | NRIX |
Nurix Therapeutics, Inc.
|
684,250 | $16,599,905 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
139,205 | $16,296,729 | |
| 6 | INSM |
INSMED Inc
|
151,960 | $16,201,975 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
63,050 | $15,432,748 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
30,685 | $15,242,160 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,242,160 | 30,685 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $19,417,791 | 43,485 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $15,529,846 | 34,255 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $18,389,456 | 46,955 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $27,359,766 | 61,455 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $32,361,735 | 66,750 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $20,135,000 | 50,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $22,207,570 | 47,750 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $25,310,880 | 54,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $23,617,565 | 56,500 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $38,654,550 | 95,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $26,602,110 | 76,500 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $22,346,285 | 63,500 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $26,308,345 | 83,500 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $23,102,400 | 80,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $27,795,840 | 96,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $26,770,050 | 95,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $23,356,815 | 89,500 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $36,234,000 | 165,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $29,929,350 | 165,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $43,531,312 | 215,897 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $36,191,988 | 168,421 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $27,179,100 | 115,000 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $29,933,200 | 110,000 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $39,917,625 | 137,500 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $27,364,250 | 115,000 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||